CJC-1295 (With DAC)

Description

CJC-1295 (With DAC) is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH) conjugated with a Drug Affinity Complex (DAC). This specific modification involves the attachment of 3-maleimidopropionic acid, which allows the peptide to form a stable bond with serum albumin in the bloodstream. This binding mechanism significantly extends the peptide’s half-life from minutes to several days, enabling sustained stimulation of the pituitary gland to release growth hormone (GH) and subsequently increase Insulin-Like Growth Factor 1 (IGF-1) levels with less frequent administration compared to standard GHRH analogues.